This transgenic mouse overexpresses the human amyloid precursor protein (APP) carrying two familial AD mutations: The Swedish mutation (KM670/671NL), which increases total A production by enhancing -secretase cleavage, and the Indiana mutation (V717F), which alters -secretase cleavage to favor production of the more aggregation-prone amyloid-beta 142 peptide (A 142 ) [464467]
Lower purity means lower effectiveness, which means longer protocols and more compound needed to achieve the same results
Abdominal subcutaneous fat provides consistent, predictable absorption
Third-generation EGFR inhibitors, including osimertinib, have demonstrated efficacy against T790M-positive disease in phase III clinical trials, while newer ALK and ROS1 inhibitors have been developed to overcome solvent-front mutations
En resumen, la investigacin preclnica sugiere un margen de seguridad amplio en animales, pero no equivale a una demostracin de seguridad en humanos